A detailed history of Steward Partners Investment Advisory, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 300 shares of BEAM stock, worth $7,986. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300
Previous 300 -0.0%
Holding current value
$7,986
Previous $9,000 22.22%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$17.69 - $30.76 $5,307 - $9,228
300 New
300 $8,000
Q2 2021

Aug 13, 2021

SELL
$64.12 - $128.71 $16,030 - $32,177
-250 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$71.28 - $120.75 $17,820 - $30,187
250 New
250 $20,000

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.87B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.